Trial Masters joins ZEINCRO to create specialist CRO in Central- and South-Eastern Europe
ZEINCRO, a specialist provider of clinical research services in Greece, Turkey and Cyprus, today announced it is consolidating with Trial Masters Ltd, a contract research organization managing clinical trials in Hungary and Romania.
Athens, Greece and Budapest, Hungary – June 11, 2012 – ZEINCRO, a specialist provider of clinical research services in Greece, Turkey and Cyprus, today announced it is consolidating with Trial Masters Ltd, a contract research organization managing clinical trials in Hungary and Romania.
With a team of more than 140 people and over a decade’s experience, the expanded ZEINCRO Group, will be ideally positioned to offer to its global drug development customers clinical trial services in a broader geographical region in Central- and South- Eastern Europe (CSEE).
“Adding Trial Masters to ZEINCRO Group will extend our geographic reach and allow us to work on larger-scale projects,” commented Prof. Gregory Sivolapenko, Chairman of ZEINCRO Group. “Both our teams have forged strong links with local authorities and the healthcare community, giving us a unique and in-depth understanding of the regions in which we operate and enabling us to deliver bespoke clinical research services that are flexible and ethical, maximizing patient recruitment and compliance.”
Supplementary to clinical research services in CSEE, ZEINCRO Group provides specialized services in risk management plans, pharmacovigilance, post-marketing safety and efficacy studies as well as regulatory affairs.
Trial Masters CEO, Dr János Demeter, added: “We are excited to be joining ZEINCRO Group. This is a natural fit as we both share the same core values and fundamental approach to successfully delivering clinical development programs. As we continue our local presence but also become part of a larger organization, we will be able to enhance the support we offer to our customers.”
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
